These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8789222)

  • 21. Tolerance of intravenous low-molecular-weight heparin after eczematous reaction to subcutaneous heparin.
    Koch P; Bahmer FA; Schäfer H
    Contact Dermatitis; 1991 Sep; 25(3):205-6. PubMed ID: 1664309
    [No Abstract]   [Full Text] [Related]  

  • 22. Delayed hypersensitivity reaction to subcutaneous heparin.
    Rivers JK; Gianoutsos MP
    Aust N Z J Surg; 1991 Nov; 61(11):865-8. PubMed ID: 1836326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low incidence of heparin-induced skin lesions in orthopedic surgery patients with low-molecular-weight heparins.
    Schindewolf M; Paulik M; Kroll H; Kaufmann R; Wolter M; Boehncke WH; Lindhoff-Last E; Recke A; Ludwig RJ
    Clin Exp Allergy; 2018 Aug; 48(8):1016-1024. PubMed ID: 29683226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type IV hypersensitivity to subcutaneous heparin: a new case.
    Gonzalo Garijo MA; Revenga Arranz F
    J Investig Allergol Clin Immunol; 1996; 6(6):388-91. PubMed ID: 9015784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid: a prospective study.
    Grassegger A; Fritsch P; Reider N
    Dermatol Surg; 2001 Jan; 27(1):47-52. PubMed ID: 11231243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed-type hypersensitivity to heparin with tolerance of its intravenous administration.
    Irion R; Gall H; Peter RU
    Contact Dermatitis; 2000 Oct; 43(4):249-50. PubMed ID: 11011948
    [No Abstract]   [Full Text] [Related]  

  • 27. Unexpected delayed-type hypersensitivity skin reactions to the ultra-low-molecular-weight heparin fondaparinux.
    Maetzke J; Hinrichs R; Schneider LA; Scharffetter-Kochanek K
    Allergy; 2005 Mar; 60(3):413-5. PubMed ID: 15679737
    [No Abstract]   [Full Text] [Related]  

  • 28. Delayed-type hypersensitivity to heparins.
    Borch JE; Bindslev-Jensen C
    Allergy; 2004 Jan; 59(1):118-9. PubMed ID: 14674951
    [No Abstract]   [Full Text] [Related]  

  • 29. Subcutaneous nodules at the injection site of low-molecular-weight heparin: a mimic of metastatic disease at CT.
    Funt SA; Hidalgo A; Panicek DM
    J Comput Assist Tomogr; 2002; 26(4):520-3. PubMed ID: 12218812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Delayed hypersensitivity to heparins and heparinoids].
    Nicolie B; Bonneau JC; Le Sellin J; Gay G; Leclere JM; Drouet M
    Allerg Immunol (Paris); 2002 Feb; 34(2):47-50. PubMed ID: 11933754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Unfractionated standard heparin versus low molecular weight heparins].
    Schrader J; Haas S
    Internist (Berl); 1993 Nov; 34(11):1053-7; discussion 1058. PubMed ID: 8282491
    [No Abstract]   [Full Text] [Related]  

  • 32. Allergy to heparins and anticoagulants with a similar pharmacological profile: an update.
    Jappe U
    Blood Coagul Fibrinolysis; 2006 Nov; 17(8):605-13. PubMed ID: 17102645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The complex clinical picture of side effects to anticoagulation.
    Trautmann A; Seitz CS
    Med Clin North Am; 2010 Jul; 94(4):821-34, xii-iii. PubMed ID: 20609865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skin tests in patients with delayed and immediate hypersensitivity to heparins: A case series.
    Tramontana M; Hansel K; Bianchi L; Agostinelli D; Stingeni L
    Contact Dermatitis; 2019 Mar; 80(3):170-172. PubMed ID: 30450556
    [No Abstract]   [Full Text] [Related]  

  • 35. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.
    van Den Belt AG; Prins MH; Lensing AW; Castro AA; Clark OA; Atallah AN; Burihan E
    Cochrane Database Syst Rev; 2000; (2):CD001100. PubMed ID: 10796593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed-type hypersensitivity to low molecular weight heparins and heparinoids: cross-reactivity does not depend on molecular weight.
    Grims RH; Weger W; Reiter H; Arbab E; Kränke B; Aberer W
    Br J Dermatol; 2007 Sep; 157(3):514-7. PubMed ID: 17573880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-immediate heparin and heparinoid cutaneous allergic reactions: a role for fondaparinux.
    Tan E; Thompson G; Ekstrom C; Lucas M
    Intern Med J; 2018 Jan; 48(1):73-77. PubMed ID: 29314514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous challenge with heparins in patients with delayed-type skin reactions after subcutaneous administration of the drug.
    Trautmann A; Bröcker EB; Klein CE
    Contact Dermatitis; 1998 Jul; 39(1):43-4. PubMed ID: 9686990
    [No Abstract]   [Full Text] [Related]  

  • 39. Delayed-type hypersensitivity to heparins: different patterns of cross-reactivity.
    Palacios Colom L; Alcántara Villar M; Luis Anguita Carazo J; Ruiz Villaverde R; Quiralte Enríquez J
    Contact Dermatitis; 2008 Dec; 59(6):375-7. PubMed ID: 19076893
    [No Abstract]   [Full Text] [Related]  

  • 40. Delayed hypersensitivity reaction to heparin.
    O'Donnell BF; Tan CY
    Br J Dermatol; 1993 Nov; 129(5):634-6. PubMed ID: 8251369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.